The newly Isothermal Nucleic Acid Amplification market report provided a complete view of the present and future market. Deep analysis of enterprise competition pattern, enterprise product advantages and disadvantages, regional industrial layout characteristics. The base year considered for the study is 2018 and the market size is projected from 2019 to 2026.
Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology, which is primarily for diagnosis of infectious diseases such as HIV-AIDS, H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB.
On the basis of products, the various types include Instrument and Reagent. The Reagent segment is expected to witness significant growth during the forecast period, owing to widespread use in hospitals and primary care settings. With the introduction of devices that are advanced in terms of accuracy, speed, and portability, the Instrument segment is projected to exhibit growth in the following years. On the basis of application, the Isothermal Nucleic Acid Amplification market is segmented into Hospitals, Central and reference labs, and Others. The hospital segment held the largest market share in 2018 and is anticipated to maintain dominance in the analyzed period.
Get FREE Sample of Isothermal Nucleic Acid Amplification Market Report at:
According to a new research study, the Isothermal Nucleic Acid Amplification market size is expected to reach USD 4,291 million by 2026 from USD 2,168 million in 2019, with a compound annual growth rate of 10.24% during the forecast period. The growth can be mainly attributed to the increasing demand for enhanced molecular testing using Isothermal Nucleic Acid Amplification Technology and the rising incidence of infectious diseases. In addition, rise in aging population across the globe and increase in adoption of isothermal nucleic acid amplification technology over other molecular diagnostic techniques are also some of the factors that propel the growth of the market. However, lack of awareness about the advanced diagnostics can pose a challenge to market growth.
Regional Segment Analysis
The report focuses on detailed analysis of major regions like North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia), and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).
North America is the global market leader with a proportion of 42.36% and a share of 32.14%. The United States accounts for the largest market share in North America, owing to the rise in infectious diseases, availability of government funds, and the prevalence of cancer in this region. Moreover, growing demand and investments from foreign players will also promote the growth of the market. Asia-Pacific is currently leading Europe with a market share of 31.24% and 28.74%. Asia-Pacific is expected to witness remarkable growth in the coming years on account of increasing prevalence rate of infectious diseases and significant adoption of novel technologies in this region. The need for cost-effective diagnostic and preventive medicine is also projected to drive the market.
Purchase a copy of Isothermal Nucleic Acid Amplification report at:
The Isothermal Nucleic Acid Amplification market is full of competition due to the presence of many large and small companies and local manufacturers. The leading vendors in the market are PreAnalytiX, Meridian Bioscience, Eiken Chemical, Lucigen, OptiGene, NEB, Biomerieux, Alere, Quidel Corporation, Promega, Hologic, Ustar, Grifols, ThermoFisher, Nugen, and others.
Target Audience for this Report
- Isothermal Nucleic Acid Amplification manufacturers
- Isothermal Nucleic Acid Amplification importers and exporters
- Isothermal Nucleic Acid Amplification traders, distributors, and suppliers
- Isothermal Nucleic Acid Amplification industry associations
- Product managers, Isothermal Nucleic Acid Amplification industry administrator, C-level executives of the industries
- Market Research and consulting firms
- Healthcare organizations
- Research & Clinical Laboratories
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Isothermal Nucleic Acid Amplification Market
2 Market Trends and Competitive Landscape
3 Segmentation of Isothermal Nucleic Acid Amplification Market by Types
4 Segmentation of Isothermal Nucleic Acid Amplification Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Isothermal Nucleic Acid Amplification Market in Major Countries
7 North America Isothermal Nucleic Acid Amplification Landscape Analysis
8 Europe Isothermal Nucleic Acid Amplification Landscape Analysis
9 Asia Pacific Isothermal Nucleic Acid Amplification Landscape Analysis
10 Latin America, Middle East & Africa Isothermal Nucleic Acid Amplification Landscape Analysis
11 Major Players Profile
11.1.1 PreAnalytiX Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Meridian Bioscience
11.3 Eiken Chemical
11.9 Quidel Corporation
Ask for a discount at:
Key questions answered in the report
- What will the market size and growth rate be in 2026?
- What segment or region will drive or lead the market growth and what are the reasons?
- How will market drivers, constraints and future opportunities affect market dynamics and subsequent analysis of relevant trends?
- What key strategies are used by top vendors to increase revenue?
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Web Site: https://www.globalmarketmonitor.com